ReticulohistiocytomaSymptoms, Doctors, Treatments, Advances & More
Learn About Reticulohistiocytoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
The Children's Hospital At Montefiore
Melissa Wasserstein is a Pediatrics provider practicing medicine in Bronx, New York. Dr. Wasserstein is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.
MN - Cancer Hematology
Jithma Abeykoon is a Hematologist practicing medicine in Rochester, Minnesota. Dr. Abeykoon is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Waldenstrom Macroglobulinemia, Reticulohistiocytoma, Histiocytosis, Tissue Biopsy, and Bone Marrow Transplant.
Rogel Cancer Center
Dr. Ahmed is a medical hematologist/oncologist with a clinical focus on lymphoma, myeloma and coagulation disorders. She was raised in Toledo, Ohio, and completed her undergraduate training at the University of Akron. After receiving her medical degree from the Medical College of Ohio in Toledo, Dr. Ahmed completed a residency in internal medicine at Saint Joseph Mercy Hospital in Ann Arbor. She then completed fellowship training in hematology/oncology at U-M. Dr. Ahmed is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Histiocytosis, Reticulohistiocytoma, Non-Langerhans-Cell Histiocytosis, Rosai-Dorfman Disease, and Bone Marrow Aspiration. Dr. Ahmed is board certified in Hematology.
Summary: This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after previous treatment, or does not respond to therapy (refractory). Langerhans cell histiocytosis is a type of disease that occurs when the body makes too ma...
Background: Niemann-Pick type C (NPC) disease is a rare, progressive neurodegenerative disease that affects mainly the brain, liver, and spleen but also other parts of the body. There is no cure for NPC, and symptoms only get worse over time. Symptoms can include seizures, difficulty moving or talking, or dementia. But symptoms can vary among different people with the disease. Some may have seizures, while ot...